Pregabalin Dosing for Post-Traumatic Neuropathic Pain

Introduction to Pregabalin Therapy

The American College of Physicians recommends initiating pregabalin at 150 mg/day (75 mg twice a day or 50 mg three times a day) and increasing to 300 mg/day within the first week, which is the optimal therapeutic dose for most patients 1

Start with 75 mg twice a day or 50 mg three times a day (total 150 mg/day) and increase to 300 mg/day within one week, as this dose provides the best benefit-risk ratio 1
For elderly patients or those at higher risk of adverse effects, consider starting with 50 mg at bedtime 2
Allow a minimum of 2-4 weeks at 300 mg/day before considering further dose increase 1

The maximum dose of 600 mg/day (300 mg twice a day or 200 mg three times a day) should be reserved for patients with inadequate pain relief at 300 mg/day who tolerate the medication well 1
Doses above 300 mg/day are not consistently more effective but significantly increase adverse effects 1

Pregabalin has linear pharmacokinetics with 90% oral bioavailability, making titration predictable 1
Pain relief occurs within 1.5-3.5 days, significantly faster than gabapentin which requires 2+ months 1
Predictable absorption allows for reliable dosing without the saturable absorption issues seen with gabapentin 2

Common dose-dependent adverse effects include dizziness (23-46%), somnolence (15-25%), and peripheral edema (10%) 1
Dry mouth and constipation are also common adverse effects 3
Gradual titration over one week minimizes these effects 1

For elderly patients, consider lower initial doses (50 mg) and slower titration 1
Patients with renal insufficiency require mandatory dose adjustment, as pregabalin is eliminated 95-98% unchanged by the kidneys 2
Reduce total daily dose by approximately 50% for creatinine clearance 30-60 mL/min, 75% for 15-30 mL/min, and 85-90% for <15 mL/min 1

Allow a minimum of 4 weeks at the therapeutic dose (typically 300 mg/day) before declaring treatment failure 1

Do not routinely prescribe 600 mg/day as a standard dose, as 300 mg/day provides the optimal benefit-risk ratio for most patients 1
Do not discontinue abruptly, instead reduce gradually over a minimum of 1 week to avoid withdrawal symptoms 1
Do not combine pregabalin with gabapentin in routine practice, especially in elderly patients, due to additive sedative effects and increased risk of falls 1
Do not use standard doses in renal insufficiency without calculating creatinine clearance and adjusting accordingly 2
Do not combine with opioids, benzodiazepines, or CNS depressants without extreme caution, as severe respiratory problems may occur 1